Identifying individuals at risk of needing CKD associated medications in a European kidney disease cohort
BMC Nephrology
by Eleni Stamellou, Turgay Saritas, Marc Froissart, Florian Kronenberg, Peter Stenvinkel, David C. Wheeler, Kai-Uwe Eckardt, Jürgen Floege and James Fotheringham
3d ago
The consequences of chronic kidney disease (CKD) can be addressed with a range of pharmacotherapies primarily prescribed by nephrologists. More accurate information regarding future CKD-related pharmacotherapy ..read more
Visit website
Establishing the Kidney dIsease in the National guarD (KIND) registry: an opportunity for epidemiological and clinical research in Saudi Arabia
BMC Nephrology
by Mohammed Tawhari, Moustafa Alhamadh, Abdulrahman Alhabeeb, Abdulaziz Ureeg, Suliman Alghnam, Fayez Alhejaili, Lubna A. Alnasser and Abdullah Sayyari
3d ago
In Saudi Arabia (SA), there has been an alarming increase in the prevalence of chronic kidney diseases (CKD) over the last three decades. Despite being one of the largest countries in the Middle East, renal co ..read more
Visit website
Ferroptosis-related genes, a novel therapeutic target for focal segmental glomerulosclerosis
BMC Nephrology
by Yanbin Lin, Jinxuan He, Zhixiang Mou, Huiting Chen, Wenkang You, Tianjun Guan and Lan Chen
3d ago
Recent studies have suggested that ferroptosis participates in various renal diseases. However, its effect on focal segmental glomerulosclerosis remains unclear. This study analyzed the GSE125779 and GSE121211 ..read more
Visit website
Mortality risk in patients with autosomal dominant polycystic kidney disease
BMC Nephrology
by Deirdre Mladsi, Xiaolei Zhou, Gregory Mader, Myrlene Sanon, Jinyi Wang, Christine Barnett, Cynthia Willey and Stephen Seliger
6d ago
Autosomal dominant polycystic kidney disease (ADPKD) is the leading inheritable cause of end-stage renal disease (ESRD). Mortality data specific to patients with ADPKD is currently lacking; thus, the aim of th ..read more
Visit website
Optimising diagnosis and management of kidney disease: an implementation trial of a clinical decision support system future health today
BMC Nephrology
by Hannah Wallace, Qiumian Wang, Tanita Botha, Barbara Hunter, Natalie Lumsden and Craig Nelson
6d ago
Chronic kidney disease affects more than 10% of the world’s population and is a non-communicable disease of global concern and priority. There is a significant implementation gap between best practice guidelin ..read more
Visit website
The ICD-9 to ICD-10 transition has not improved identification of rapidly progressing stage 3 and stage 4 chronic kidney disease patients: a diagnostic test study
BMC Nephrology
by Kabir Jalal, Andre Charest, Xiaoyan Wu, Richard J. Quigg and Shirley Chang
6d ago
The International Classification of Diseases (ICD) coding system is the industry standard tool for billing, disease classification, and epidemiology purposes. Prior research has demonstrated ICD codes to have ..read more
Visit website
The differential effect of modern intravenous iron on fibroblast growth factor 23 and phosphate in non-dialysis dependent CKD – the exploratory randomized controlled double-blind ExplorIRON-CKD study
BMC Nephrology
by Xenophon Kassianides and Sunil Bhandari
1w ago
Intravenous iron is commonly used in patients with non-dialysis-dependent chronic kidney disease (CKD). Modern intravenous iron compounds (e.g. ferric derisomaltose (FDI), ferric carboxymaltose (FCM)) are incr ..read more
Visit website
Steroid-resistant minimal change nephrotic syndrome associated with thymoma treated effectively with rituximab following thymectomy and cyclosporine: a case report
BMC Nephrology
by Yusaku Watanabe, Keiji Hirai, Momoko Hirata, Taisuke Kitano, Kiyonori Ito, Susumu Ookawara, Hisashi Oshiro and Yoshiyuki Morishita
1w ago
Minimal change nephrotic syndrome (MCNS) can be complicated by thymoma; however, no standard therapy for thymoma-associated MCNS has yet been established. We herein describe a case of steroid-resistant MCNS as ..read more
Visit website
Nephrotic syndrome with acute kidney injury due to combination therapy of immune checkpoint inhibitors: a case report and review of the literature
BMC Nephrology
by Ryosuke Saiki, Kan Katayama, Haruko Saiki, Ayumi Fukumori, Kayo Tsujimoto, Masahiro Yamawaki, Fumika Tanaka, Daisuke Takahashi, Keiko Oda, Yasuo Suzuki, Tomohiro Murata and Kaoru Dohi
1w ago
Recent studies have focused on immune checkpoint inhibitors. Renal complications associated with the use of immune checkpoint inhibitors are uncommon compared with other immune-related adverse events. Acute in ..read more
Visit website
Quality-of-life measures and their psychometric properties used in African chronic kidney disease populations: a systematic review using COSMIN methodology
BMC Nephrology
by Moustapha Faye, Florian Manneville, Adama Faye, Luc Frimat and Francis Guillemin
1w ago
If any benefit is to be derived from the use of the health-related quality of life (HRQoL) questionnaires in chronic kidney disease (CKD) patients, they should be validated and culturally adapted to the target ..read more
Visit website

Follow BMC Nephrology on FeedSpot

Continue with Google
Continue with Apple
OR